PE20100713A1 - Gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina - Google Patents
Gel oral endoparasiticida bioadhesivo de larga accion a base de doramectinaInfo
- Publication number
- PE20100713A1 PE20100713A1 PE2010000469A PE2010000469A PE20100713A1 PE 20100713 A1 PE20100713 A1 PE 20100713A1 PE 2010000469 A PE2010000469 A PE 2010000469A PE 2010000469 A PE2010000469 A PE 2010000469A PE 20100713 A1 PE20100713 A1 PE 20100713A1
- Authority
- PE
- Peru
- Prior art keywords
- doramectin
- acting
- long
- bioadhesive
- endoparasiticide
- Prior art date
Links
- 239000000227 bioadhesive Substances 0.000 title abstract 2
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 title abstract 2
- 229960003997 doramectin Drugs 0.000 title abstract 2
- 229940041672 oral gel Drugs 0.000 title 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 abstract 2
- -1 SACROSE Chemical compound 0.000 abstract 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 abstract 2
- 229910052708 sodium Inorganic materials 0.000 abstract 2
- 239000011734 sodium Substances 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 239000004376 Sucralose Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003086 colorant Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 abstract 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 abstract 1
- 229960003415 propylparaben Drugs 0.000 abstract 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 abstract 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 abstract 1
- 235000019408 sucralose Nutrition 0.000 abstract 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
REFERIDA A UNA COMPOSICION ENDOPARASITICIDA BAJO LA FORMA DE GEL BIOADHESIVO DE LARGA ACCION QUE COMPRENDE: a) DE 0,50% A 5% P/V DE DORAMECTINA; b) 1% A 10% P/V DE UN SOLVENTE ORGANICO TAL COMO N-METIL-2-PIRROLIDONA, 2-PIRROLIDONA, ALCOHOL BENCILICO, ENTRE OTROS; c) DE 10% A 60% P/V DE POLIVINILPIRROLIDONA; d) DE 25% A 95% V/V DE UN DILUYENTE TAL COMO PROPILENGLICOL, POLIETILENGLICOL, GLICERINA, ENTRE OTROS; e) DE 0,10% A 4% P/V DE UN AGENTE EDULCORANTE TAL COMO SUCRALOSA SODICA, SACAROSA, SACARINA SODICA, ENTRE OTROS; f) DE 0,10% A 4% P/V DE UN AGENTE AROMATIZANTE; g) DE 0,10% A 1% DE UN AGENTE CONSERVANTE TAL COMO METILPARABENO, PROPILPARABENO, BUTILPARABENO, ENTRE OTROS Y h) DE 0,001% A 0,010% P/V DE UN AGENTE COLORANTE. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO ENDOPARASITICIDA EN MAMIFEROS, PRINCIPALMENTE, EQUINOS
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PE2010000469A PE20100713A1 (es) | 2008-09-19 | 2009-08-28 | Gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PE0015512008 | 2008-09-19 | ||
| PE2010000469A PE20100713A1 (es) | 2008-09-19 | 2009-08-28 | Gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20100713A1 true PE20100713A1 (es) | 2010-10-13 |
Family
ID=42039956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2010000469A PE20100713A1 (es) | 2008-09-19 | 2009-08-28 | Gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8455452B2 (es) |
| EP (1) | EP2345413A4 (es) |
| CN (1) | CN102202671A (es) |
| AU (1) | AU2009294293A1 (es) |
| BR (1) | BRPI0913753B1 (es) |
| CA (1) | CA2737671A1 (es) |
| CR (1) | CR20110207A (es) |
| EA (1) | EA022209B1 (es) |
| MX (1) | MX2009001235A (es) |
| PE (1) | PE20100713A1 (es) |
| WO (1) | WO2010032113A2 (es) |
| ZA (1) | ZA201102793B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013137748A1 (en) * | 2012-03-13 | 2013-09-19 | Bayer New Zealand Limited | Long acting compositions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN933396A0 (en) * | 1996-04-17 | 1996-05-09 | Pfizer Pty Limited | Non-aqueuos oral-drench compositions containing avermectin compounds |
| AU707949C (en) | 1996-07-30 | 2006-01-19 | Merial, Inc. | Anthelmintic formulations |
| GB9827727D0 (en) * | 1998-12-16 | 1999-02-10 | Pfizer Ltd | Antiparasitic formulations |
| US6893652B2 (en) | 2001-08-27 | 2005-05-17 | Wyeth | Endoparasiticidal gel composition |
| PT2347654T (pt) * | 2001-09-17 | 2019-05-30 | Elanco Us Inc | Formulação para o controlo de piolhos ou carrapatos em bovinos |
| US7001889B2 (en) * | 2002-06-21 | 2006-02-21 | Merial Limited | Anthelmintic oral homogeneous veterinary pastes |
| US20080027011A1 (en) * | 2005-12-20 | 2008-01-31 | Hassan Nached | Homogeneous paste and gel formulations |
-
2009
- 2009-01-30 MX MX2009001235A patent/MX2009001235A/es active IP Right Grant
- 2009-08-28 PE PE2010000469A patent/PE20100713A1/es active IP Right Grant
- 2009-08-28 WO PCT/IB2009/006867 patent/WO2010032113A2/es not_active Ceased
- 2009-08-28 CN CN2009801368925A patent/CN102202671A/zh active Pending
- 2009-08-28 EP EP09814154.2A patent/EP2345413A4/en not_active Withdrawn
- 2009-08-28 BR BRPI0913753A patent/BRPI0913753B1/pt not_active IP Right Cessation
- 2009-08-28 EA EA201170470A patent/EA022209B1/ru not_active IP Right Cessation
- 2009-08-28 US US13/062,419 patent/US8455452B2/en not_active Expired - Fee Related
- 2009-08-28 CA CA2737671A patent/CA2737671A1/en not_active Abandoned
- 2009-08-28 AU AU2009294293A patent/AU2009294293A1/en not_active Abandoned
-
2011
- 2011-04-14 ZA ZA2011/02793A patent/ZA201102793B/en unknown
- 2011-04-25 CR CR20110207A patent/CR20110207A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US8455452B2 (en) | 2013-06-04 |
| CR20110207A (es) | 2011-09-06 |
| US20110160155A1 (en) | 2011-06-30 |
| BRPI0913753A2 (pt) | 2015-10-20 |
| EA201170470A1 (ru) | 2011-10-31 |
| EP2345413A4 (en) | 2013-11-20 |
| CN102202671A (zh) | 2011-09-28 |
| WO2010032113A2 (es) | 2010-03-25 |
| MX2009001235A (es) | 2010-04-29 |
| CA2737671A1 (en) | 2010-03-25 |
| EP2345413A2 (en) | 2011-07-20 |
| EA022209B1 (ru) | 2015-11-30 |
| WO2010032113A3 (es) | 2010-06-17 |
| ZA201102793B (en) | 2011-12-28 |
| AU2009294293A1 (en) | 2010-03-25 |
| BRPI0913753B1 (pt) | 2018-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU23999B1 (es) | Solución no-acuosa tópica de diclofenaco y proceso para su preparación | |
| BR112015019657A2 (pt) | composições tópicas e métodos de uso das mesmas | |
| BR112014000178A2 (pt) | composições tópicas | |
| MX2009001203A (es) | Muteinas de lipocalina lacrimosa y metodos para obtener las mismas. | |
| MX2011009131A (es) | Composiciones aditivas espesantes. | |
| MA31953B1 (fr) | Nouveaux derives du thiophene. | |
| AR062170A1 (es) | Una composicion y metodo para hacer un propulsor | |
| PE20140936A1 (es) | Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas | |
| CO7240372A2 (es) | Formulaciones farmacéuticas tópicas no acuosas | |
| ECSP10010556A (es) | Piridinas y pirazinas como inhibidores de pi3k | |
| MX353841B (es) | Composiciones antimicrobianas y metodos de uso. | |
| CO6390116A2 (es) | Métodos y composiciones para la remoción de tatuajes | |
| CL2011000222A1 (es) | Uso de una composicion que contiene a) quitosano o hidroxipropil quitosano, b) al menos un ingrediente seleccionado de inhibidores de alfa-5-reductasa, hormonas antiandrogenicas, agonistas del canal de potasio y extractos vegetales, c) etanol o isopropanol, para el tratamiento o prevencion de afecciones del cabello o cuero cabelludo tales como caida del cabello, alopecia, alopecia androgenica, entre otras. | |
| DOP2011000354A (es) | Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas | |
| CY1116111T1 (el) | Τοπικη συνθεση για τη θεραπεια της ακτινικης κερατωσης | |
| ECSP10010106A (es) | Trans-clomifeno para el síndrome metabólico | |
| UY31273A1 (es) | Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53 | |
| BRPI0719277A2 (pt) | Formulação fitossanitária concentrada, utilização da formulação e composição solvente compreendendo uma mistura de solventes | |
| WO2008067436A3 (en) | Compounds and formulations suitable for radical scavenging | |
| BR112012015437A2 (pt) | composição tópica substancialmente anidra de armazenamento estável | |
| PE20100713A1 (es) | Gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina | |
| ECSP088545A (es) | Composición para prevenir o tratar daños de la mucosa en los conductos gastrointestinales | |
| BR112014013183A2 (pt) | composições para cuidado oral compreendendo n-butil magnolol e isobutil magnolol | |
| MX386105B (es) | Composiciones para el cuidado bucal y metodos de uso. | |
| PE20211218A1 (es) | Suspensiones liquidas de paracetamol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |